Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Versatile Role of miR-21 in Renal Homeostasis and Diseases. | Cells | 2022 | 36359921 | PubTator, text mining | PubMed |
| Emerging Role of YAP and the Hippo Pathway in Prostate Cancer. | Biomedicines | 2022 | 36359354 | PubTator, text mining | PubMed |
| UM-164, a Dual Inhibitor of c-Src and p38 MAPK, Suppresses Proliferation of Glioma by Reducing YAP Activity. | Cancers (Basel) | 2022 | 36358761 | PubTator, text mining | PubMed |
| TNS1: Emerging Insights into Its Domain Function, Biological Roles, and Tumors. | Biology (Basel) | 2022 | 36358270 | PubTator, text mining | PubMed |
| Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated. | Cancer Cell Int | 2022 | 36348319 | PubTator, text mining | PubMed |
| Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells. | Nat Commun | 2022 | 36347861 | PubTator, text mining | PubMed |
| The Hippo signalling pathway and its implications in human health and diseases. | Signal Transduct Target Ther | 2022 | 36347846 | PubTator, text mining | PubMed |
| Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response. | PLoS Biol | 2022 | 36346780 | PubTator, text mining | PubMed |
| Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. | NPJ Breast Cancer | 2022 | 36344517 | PubTator, text mining | PubMed |
| SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma. | Cell Death Discov | 2022 | 36335095 | PubTator, text mining | PubMed |
| Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma. | Front Genet | 2022 | 36330438 | PubTator, text mining | PubMed |
| Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring. | Front Immunol | 2022 | 36325354 | PubTator, text mining | PubMed |
| Multiphase coalescence mediates Hippo pathway activation. | Cell | 2022 | 36318920 | PubTator, text mining | PubMed |
| Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis. | Circulation | 2022 | 36317529 | PubTator, text mining | PubMed |
| Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling. | Elife | 2022 | 36300789 | PubTator, text mining | PubMed |
| A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway. | iScience | 2022 | 36300003 | PubTator, text mining | PubMed |
| Copper(II) Complex Containing 4-Fluorophenoxyacetic Acid Hydrazide and 1,10-Phenanthroline: A Prostate Cancer Cell-Selective and Low-Toxic Copper(II) Compound. | Molecules | 2022 | 36296690 | PubTator, text mining | PubMed |
| Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. | Int J Mol Sci | 2022 | 36293239 | PubTator, text mining | PubMed |
| The Emerging Roles of Protein Interactions with O-GlcNAc Cycling Enzymes in Cancer. | Cancers (Basel) | 2022 | 36291918 | PubTator, text mining | PubMed |
| Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. | Cells | 2022 | 36291095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=32